• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

61st Congress of the Brazilian Society of Tropical Medicine (Medtrop 2026)

16-19 August 2026

Brasilia, Brazil

MedTrop 2026, the 61st Congress of the Brazilian Society of Tropical Medicine, will bring together a diverse community of researchers, healthcare professionals, and students working on tropical medicine and public health. Under the theme “Health in the Tropics: An Integrative Vision from a Global South Perspective,” the congress will highlight the realities and priorities of those on the front lines of population health, with a focus on partnerships and collaboration across regions facing similar tropical health challenges.

The program will feature scientific research, implementation science, and hands-on training on strategies for tropical disease prevention and control, welcoming researchers, health professionals, policymakers, and civil society alike.

DNDi participation:

Pre-Congress Course

ASTMH Update Course in Clinical Tropical Medicine

Date: 16 August 2026
Time: 8:00 – 17:00
Room: T4
Coordinator: Kleber Giovanni Luz, UFRN (Brazil)
Speakers: Aisha Khatib, ASTMH (Canada); German Henostroza, Astmh (Brazil); Carlos Seas, Peruvian Cayetano University (Peru); Lessandra Michelin, University of Caxias do Sul (Brazil); Karis Maria De Pinho Rodrigues, UFRJ (Brazil) ; Alejandro Lepetic, GSK (Brazil); André Siqueira, DNDi (Brazil)
Debater: Marcelo Simão Ferreira, Federal University of Uberlândia (Brazil)

Workshops

LV Brazil Network: Building a National Cohort to Transform Clinical Management and Research in Visceral Leishmaniasis (Part 1)

Date: 15 August 2026
Time: 8:00 – 12:00
Room: T6
Coordinator: Glaucia Fernandes Cota, DNDi (Brazil)

LV Brazil Network: Building a National Cohort to Transform Clinical Management and Research in Visceral Leishmaniasis (Part 2)

Date: 16 August 2026
Time: 8:00 – 12:00
Room: M8
Coordinator: Glaucia Fernandes Cota, DNDi (Brazil)

Conference

Technology and innovation to save children from infectious diseases.

Date: 17 August 2026
Time: 11:00 – 12:00
Room: T4
Moderator: André Siqueira, DNDi (Brazil)
Speaker: Quique Bassat, Barcelona Insitute for Global Health (ISGlobal) (Spain)

Roundtables

Strategies for malaria prevention, control, and elimination in the Yanomami and Ye’kwana Special Indigenous Health District.

Date: 18 August 2026
Time: 14:00 – 15:30
Room: T4
Moderator: Joao Luiz Pereira De Araujo, SVSA (Brazil)

Epidemiological dynamics and reorganization of malaria control strategies in the Yanomami and Ye’kwana territory.
Time: 14:00 – 14:20
Speaker: Ivyson Da Silva Epifânio, Yanomami Special Indigenous Health District (DSEIY), (Brazil)
Community-based treatment of Plasmodium falciparum outbreaks in remote areas: operational challenges and impact on transmission control.
Time: 14:20 – 14:40
Speaker: Oneron De Abreu Pithan, Yanomami Special Indigenous Health District (DSEIY), (Brazil)
Challenges and perspectives of malaria in the Yanomami Indigenous Territory
Time: 14:40 – 15:00
Speaker: André Siqueira, DNDi (Brazil)
Discussion
Time: 17:00 – 17:30

Development of Dengue Treatments: Which Path and What Comes Along With It?

Date: 18 August 2026
Time: 16:00 – 17:30
Room: T4
Moderator: Viviane Boaventura, Fiocruz (Brazil)

Screening and selection of candidates for dengue fever.
Time: 16:00 – 16:20
Speaker: Mauro Teixeira, UFMG (Brazil)
Host-directed therapies as a strategy to reduce the risk of progression to severe dengue.
Time: 16:20 – 16:40
Speaker: André Siqueira, DNDi (Brazil)
Biomarkers and diagnostics for dengue treatment
Time: 16:40 – 17:00
Speaker: Quique Bassat, Barcelona Insitute for Global Health (ISGlobal) (Spain)
Bedside ultrasound in tropical diseases
Time: 17:00 – 17:20
Speaker: Benno Kreuels, Bernhard Nocht Institute For Tropical Medicine (Germany)
Discussion
Time: 17:20 – 17:30

Mucosal leishmaniasis: challenges in clinical practice.

Date: 19 August 2026
Time: 16:00 – 17:30
Room: M12
Moderator: Jose Angelo Lauletta Lindoso, Emilio Ribas Institute Of Infectious Diseases (Brazil)

Treatment of mucosal leishmaniasis.
Time: 16:00 – 16:40
Speaker: Alejandro Llano’s Cuentas (Peru)
Treatment of mucosal leishmaniasis in the New World: a randomized comparison of glucantime, liposomal amphotericin B, and miltefosine.
Time: 16:20 – 16:40
Speaker: Jaime Soto, Funderma (Bolivia)
Miltefosine versus liposomal amphotericin B in the treatment of mucosal leishmaniasis.
Time: 16:40 – 17:00
Speaker: Glaucia Fernandes Cota, DNDi (Brazil)
Discussion
Time: 17:00 – 17:30

Why is the diagnosis of Chagas disease entering a new phase?

Date: 19 August 2026
Time: 16:00 – 17:30
Room: M11
Moderator: Fred Luciano Neves Santos, Gonçalo Moniz Institute (Brazil)

Comparative evaluation of molecular methods for the diagnosis of oral Chagas disease in the Amazon region: the DiAChO study (Diagnosis of Oral Chagas Disease).
Time: 16:00- 16:20
Speaker: Otacilio Da Cruz Moreira, Fiocruz (Brazil)
Expanding access to diagnosis and care for Chagas disease: from knowledge to action in the Oxente Chagas Bahia program.
Time: 16:20 – 16:40
Speaker: Fred Luciano Neves Santos, Gonçalo Moniz Institute (Brazil)
Inclusion of rapid tests in the algorithm for Chagas disease diagnosis in Colombia: from scientific evidence to public policy.
Time: 16:40 – 17:00
Speaker: Andrea Marchiol, DNDi (Argentina)
Discussion
Time: 17:00 – 17:30

Research networks in Chagas disease and leishmaniasis: a perspective from the Global South.

Date: 19 August 2026
Time: 16:00 – 17:30
Room: M13

International Network for Care and Study of T. cruzi/HIV Coinfection and other Immunosuppressive Conditions.
Time: 16:00- 16:15
Speaker: Marisa Liliana Fernandez, FJ Muñiz Hospital (Argentina)
Global Triatomine Network
Time: 16:15 – 16:30
Speaker: Soledad Ceccarelli, (Argentina)
Leishmaniasis and HIV co-infection network
Time: 16:30 – 16:45
Speaker: Marcia Hueb, UFMT (Brazil)
Leish Network
Time: 16:45 – 17:00
Speaker: Joelle Rode, DNDi (Brazil)
Discussion
Time: 17:00 – 17:30

Equity on the Neglected Tropical Diseases Agenda: Inclusion of underrepresented populations in clinical development, public policies, and access to treatment.

Date: 19 August 2026
Time: 16:00 – 17:30
Room: M10
Moderator: Fabiana Piovesan Alves, DNDi (Brazil)

Challenges and pathways for pediatric inclusion in clinical development in NTDs
Time: 16:00- 16:20
Speaker: Dorcas Lamounier Costa, Federal University of Piauí (Brazil)
Women of childbearing age: between risk, protection, and exclusion — strategies to increase the representation of women in clinical studies and promote access to treatment.
Time: 16:20 – 16:40
Speaker: Fabiana Piovesan Alves, DNDi (Brazil)
Nothing about us without us: the role of patients in shaping the research agenda, public policies, and access in NTDs.
Time: 16:40 – 17:00
Speaker: Alexsandro Souza Do Lado, UFBA (Brazil)
From research to policy: social participation as a central element for the inclusive design of clinical trials and public policies in NTDs
Time: 17:00 – 17:20
Speaker: Felipe Proenço, SGTES/MS, Ministry of Health (Brazil)
Discussion
Time: 17:20- 17:30

Mini-Conferences

No Time to Wait – Critical Need for One Health Global Alliance (OHGA) to Address Complex Public Health Priorities

Date: 17 August 2026
Time: 10:00 – 10:30
Room: M9

Speaker: Wondwossen Gebreye, Ohio State University (USA)
Moderator: André Siqueira, DNDi (Brazil)

How partnerships advance research in DNA: lessons from DNDi’s collaborative innovation model.

Date: 18 August 2026
Time: 10:00 – 10:30
Room: M11

Speaker: Sergio Sosa Estani, DNDi (Brazil)
Moderator: Ana Rabello, Fiocruz (Brazil)

Preparedness and response to public health emergencies, from acute lack of care to reorganization of care.

Date: 19 August 2026
Time: 10:00 – 10:30
Room: Planalto Theater

Speaker: Rodrigo Stabeli, Ministry Of Health (Brazil)
Moderator: André Siqueira, DNDi (Brazil)

When the research bench meets the hinterland: translational science, diagnostic innovation, and the path of rapid testing – Chagas disease to the Brazilian public health system (SUS).

Date: 19 August 2026
Time: 10:30 – 11:00
Room: T4

Speaker: Fred Luciano Neves Santos, Gonçalo Moniz Insitute (Brazil)
Moderator: Fabiana Piovesan Alves, DNDi (Brazil)

Open Topics

Session 05 MEDTROP

Date: 17 August 2026
Time: 12:00 – 13:20
Room: M7

Evaluators: André Siqueira, DNDi (Brazil); Tania Do Socorro Souza Chaves, Evandro Chagas Institute (Brazil)

e-Poster

Contraception requirements and women’s access to treatment and research in leishmaniasis and Chagas disease in Latin America: findings from Brazil and Colombia.
Authors: Gláucia Cota, Fabiana Alves, Leo Persoz, Andrea Marchiol, Rafael Herazo, Diogo Galvão, Luiz Henrique Guimarães, Alex Lago, Denise Pimenta, Polyana Valente, Ana Flávia Nery, Maria Jesus Pinazo

More information

Event website

Climate change Drug discovery Partnership Strengthening Capacities Chagas disease Cutaneous leishmaniasis Visceral leishmaniasis Latin America

Other events

Loading...
11-13 October 2026

Berlin, Germany & Online

World Health Summit 2026

14-17 September

Copenhagen, Denmark

Hepatitis C virus, flaviviruses and related viruses (HCV-Flavi) 2026

25-28 August 2026

Addis Ababa, Ethiopia

Seventy-sixth session of the WHO Regional Committee for Africa

22-25 July 2026

Curitiba, Brazil

23rd Infocus | 2nd ISHAM Latam

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Youtube Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license